| Product Name |
MF |
CAS |
Details |
| Cholesteryl chloride |
C27H45Cl |
910-31-6 |
|
| 5-Methyl-3-oxohexanoic acid methyl ester |
C8H14O3 |
30414-55-2 |
|
| 3-Chloro-5-fluorophenylboronic acid |
C6H5BClFO2 |
328956-61-2 |
|
| 3,3',5,5'-Tetraisopropylbiphenyl-4,4'-diol |
C24H34O2 |
2416-95-7 |
|
| Dazomet |
C5H10N2S2 |
533-74-4 |
|
| 4,4'-DINITRODIPHENYL ETHER |
C12H8N2O5 |
101-63-3 |
|
| Bis(triphenylphosphinepalladium) acetate |
C40H36O4P2Pd |
14588-08-0 |
|
| 5-Methylthiophene-2-carboxaldehyde |
C6H6OS |
13679-70-4 |
|
| COLURACETAM |
C19H23N3O3 |
135463-81-9 |
|
| 3,5,6-TRIFLUORO-PYRIDIN-2-YLAMINE |
C5H3F3N2 |
3534-50-7 |
|
| COUMACHLOR |
C19H15ClO4 |
81-82-3 |
|
| 1-Boc-pyrrolidine-3-carboxylic acid |
C10H17NO4 |
59378-75-5 |
|
| MONO-METHYL SUCCINATE |
C5H8O4 |
3878-55-5 |
|
| Sucralfate |
C11H52Al16O75S8-16 |
54182-58-0 |
|
| 2-Dimethylamino-1,3-di(thiocyanato)propane |
C7H11N3S2 |
997-70-6 |
|
| ACID VIOLET 43 |
C21H16NNaO6S |
4430-18-6 |
|
| CANGRELOR |
C17H25Cl2F3N5O12P3S2 |
163706-06-7 |
|
| SINOMENINE HYDROCHLORIDE |
C19H23NO4.ClH |
6080-33-7 |
|
| 2-Aminobenzimidazole |
C7H7N3 |
934-32-7 |
|
| 4-FORMYLCINNAMIC ACID METHYL ESTER |
C11H10O3 |
58045-41-3 |
|
| 4-Trifluoromethylsalicylic acid |
C8H5F3O3 |
328-90-5 |
|
| 4-Trifluoromethylsalicylic acid |
C8H5F3O3 |
328-90-5 |
|
| (E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE |
C24H29N3O2 |
658084-64-1 |
|
| TERT-BUTYL 2,4-DIOXOPIPERIDINE-1-CARBOXYLATE |
C10H15NO4 |
845267-78-9 |
|
| 06035642G6 |
C54H84O23 |
158800-83-0 |
|
| 1H-1,2,3-TRIAZOLE, 4-BROMO-1-METHYL- |
C3H4BrN3 |
13273-53-5 |
|
| TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE |
C16H28BNO4 |
885693-20-9 |
|
| 4-PYRIMIDINECARBOXYLIC ACID, 1,6-DIHYDRO-5-HYDROXY-2-[1-METHYL-1-[[(PHENYLMETHOXY)CARBONYL]AMINO]ETHYL]-6-OXO-, METHYL ESTER |
C17H19N3O6 |
519032-08-7 |
|
| 8-CHLOROQUINAZOLIN-4(1H)-ONE |
C8H5ClN2O |
101494-95-5 |
|
| 1-BROMO-4-NAPHTHALDEHYDE |
C11H7BrO |
50672-84-9 |
|
| 4,4'-DIBROMO-3,3'-DIMETHYLBIPHENYL |
C14H12Br2 |
61794-96-5 |
|
| 6-CHLORO-5-METHYLPYRIDINE-3-CARBALDEHYDE |
C7H6ClNO |
176433-43-5 |
|
| 4-chloro-3-iodoaniline |
C6H5ClIN |
573764-31-5 |
|
| 2,2-Dimethyl-4-oxocyclohexanecarboxylic acid |
C9H14O3 |
4029-26-9 |
|
| 1H-PYRROLO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER |
C10H10N2O2 |
24334-19-8 |
|
| TERT-BUTYL-N-METHYLCARBAMATE |
C6H13NO2 |
16066-84-5 |
|
| 2-AMINO-4-CHLOROPHENYL BORONIC ACID PINACOL ESTER |
C12H17BClNO2 |
863578-21-6 |
|
| 2,3-DIHYDRO-1H-ISOINDOL-1-ONE-4-BORONIC ACID PINACOL ESTER |
C14H18BNO3 |
765948-78-5 |
|
| ISOQUINOLIN-3-AMINE |
C9H8N2 |
25475-67-6 |
|
| 1-BOC-4-(6-AMINOPYRIDIN-3-YL)PIPERAZINE |
C14H22N4O2 |
571188-59-5 |
|
| OTAVA-BB 1207229 |
C14H22N4O2 |
571188-59-5 |
|
| 3-OXA-8-AZABICYCLO[3.2.1]OCTANE, HYDROCHLORIDE (1:1) |
C6H12ClNO |
904316-92-3 |
|
| (S)-1-(5-PHENYL-1H-IMIDAZOL-2-YL)ETHANAMINE |
C11H13N3 |
864825-23-0 |
|
| ANTHRACENE, 9-(2-NAPHTHALENYL)-10-[4-(1-NAPHTHALENYL)PHENYL]- |
C40H26 |
667940-34-3 |
|
| 1-ADAMANTANE CARBOXALDEHYDE |
C11H16O |
2094-74-8 |
|
| 4-(4-Ethylcyclohexyl)cyclohexanone |
C14H24O |
150763-13-6 |
|
| 6-dimethylamino-4-methyl-pyridineboronic acid |
C8H13BN2O2 |
535934-70-4 |
|
| 9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one |
C12H10ClN3O |
84661-23-4 |
|
| Evodine |
C18H19NO5 |
6989-38-4 |
|
| Aluminium chloride |
AlCl3 |
7446-70-0 |
|
| 2,3,6-TRICHLOROQUINOXALINE |
C8H3Cl3N2 |
2958-87-4 |
|
| 3,6-Dihydroxypyridazine |
C4H4N2O2 |
123-33-1 |
|
| 2-Mercapto-1,3,4-thiadiazol |
C2H2N2S2 |
18686-82-3 |
|
| Tigecycline |
C29H39N5O8 |
220620-09-7 |
|
| 4-Ethoxy-2,6-difluorophenylboronic acid |
C8H9BF2O3 |
1310403-94-1 |
|
| tert-butyl 2-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate |
C13H21NO4 |
301226-27-7 |
|
| tert-Butyl2,7-diazaspiro[3.5]nonane-7-carboxylatehydrochloride |
C12H22ClN2O2- |
1023301-84-9 |
|
| Riociguat |
C20H19FN8O2 |
625115-55-1 |
|
| 3-(Methylsulfonyl)Benzenemethanamine |
C8H11NO2S |
771573-22-9 |
|
| 8-Bromo-1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctane |
C8H4BrF13 |
161583-34-2 |
|
| Dabigatran etexilate |
C34H41N7O5 |
211915-06-9 |
|
| 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester |
C14H19N3O2 |
3543-73-5 |
|
| (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone |
C13H15NO3 |
101711-78-8 |
|
| 1-benzyl-4-methylpiperidin-3-one |
C13H17NO |
32018-96-5 |
|
| ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate |
C14H17N3O4 |
3543-72-4 |
|
| 4,6-DIHYDROXY-5-NITROPYRIMIDINE |
C4H3N3O4 |
2164-83-2 |
|
| N-(12-Aminododecyl)-1-deoxynojirimycin |
C12H26N2O4 |
885484-41-3 |
|
| 4-Ethynyl-4'-propyl-1,1'-Biphenyl |
C17H16 |
360768-57-6 |
|
| Anacetrapib |
C30H25F10NO3 |
875446-37-0 |
|
| 4'-Methoxyresveratrol |
C15H14O3 |
33626-08-3 |
|
| Glycyl-L-prolyl-L-arginyl-L-prolyl-L-alaninamide |
C21H37N9O5 |
135679-88-8 |
|
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester |
C18H16N4O2 |
917392-54-2 |
|
| Potassium fluoroaluminate |
AlF4.K |
14484-69-6 |
|
| N-(3-(Trimethoxysilyl)propyl)butylamine |
C10H25NO3Si |
31024-56-3 |
|
| 2-bromobenzo[9,10]phenanthrene |
C18H11Br |
19111-87-6 |
|
| Besifloxacin hydrochloride |
C19H22Cl2FN3O3 |
405165-61-9 |
|
| METHOXYFENOZIDE |
C22H28N2O3 |
161050-58-4 |
|
| REF DUPL: Fmoc-Asp(OtBu)-(Dmb)Gly-OH |
C34H38N2O9 |
900152-72-9 |
|
| 3-Chloroisonicotinic acid |
C6H4ClNO2 |
88912-27-0 |
|
| 6-Bromo-3-iodoimidazo[1,2-a]pyrazine |
C6H3BrIN3 |
1245644-42-1 |
|
| 1,1':4',1''-Terphenyl, 2,3'',4'',5''-tetrafluoro-4-propyl- |
C21H16F4 |
205806-88-8 |
|
| 1,1':4',1''-Terphenyl, 2,3'',4'',5''-tetrafluoro-4-propyl- |
C21H16F4 |
205806-88-8 |
|
| N,N,N'-Triphenyl-4,4'-bianiline |
C30H24N2 |
167218-30-6 |
|
| 4-[2-(Methylamino)ethyl]phenol hydrochloride |
C9H13NO.ClH |
13062-76-5 |
|
| 4-[2-(Methylamino)ethyl]phenol hydrochloride |
C9H13NO.ClH |
13062-76-5 |
|
| 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-fluoro-6-methoxy-3-quinolinecarbonitrile |
C18H12Cl2FN3O2 |
622369-46-4 |
|
| 2-(2-Nitrophenoxy)ethylamine Hydrochloride |
C8H11ClN2O3 |
98395-65-4 |
|
| Benzen |
C20H32 |
89363-50-8 |
|
| 1H-Indazol-3-ol |
C7H6N2O |
100922-96-1 |
|
| 1H-Indazole, 5-bromo-7-iodo- |
C7H4BrIN2 |
953410-86-1 |
|
| 19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-hydroxy-, cyclic 3-(1,2-ethanediyl acetal) |
C22H30O4 |
42982-49-0 |
|
| tert-butyl 4,4-difluoropiperidine-1-carboxylate |
C10H17F2NO2 |
281652-10-6 |
|
| tert-butyl 4,4-difluoropiperidine-1-carboxylate |
C10H17F2NO2 |
281652-10-6 |
|
| 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N |
C21H16F4N4O2S |
915087-33-1 |
|
| L-Glutamic acid 5-tert-butyl 1-methyl ester hydrochloride |
C10H20ClNO4 |
6234-01-1 |
|
| α-amine-ω-propionic acid diethylene glycol |
C7H15NO4 |
791028-27-8 |
|
| 1-Acetyladamantane Intermediate |
C10H19NO4 |
274693-55-9 |
|
| Afatinib |
C24H25ClFN5O3 |
850140-72-6 |
|
| Afatinib |
C24H25ClFN5O3 |
850140-72-6 |
|
| Afatinib |
C24H25ClFN5O3 |
850140-72-6 |
|
